Valery Volk

649 total citations
12 papers, 164 citations indexed

About

Valery Volk is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Valery Volk has authored 12 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Valery Volk's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Virus-based gene therapy research (2 papers). Valery Volk is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Virus-based gene therapy research (2 papers). Valery Volk collaborates with scholars based in Germany, France and Belgium. Valery Volk's co-authors include Friedrich Feuerhake, Sebastian J. Theobald, Wilfried Gwinner, Constança Figueiredo, Renata Stripecke, Jessica Schmitz, Constantin von Kaisenberg, Haralampos Hatzikirou, Andreas Schneider and Arnold Ganser and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and American Journal Of Pathology.

In The Last Decade

Valery Volk

11 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valery Volk Germany 6 72 62 45 34 30 12 164
Zheng Su China 8 36 0.5× 112 1.8× 96 2.1× 31 0.9× 15 0.5× 15 231
Yiqun Jiang China 9 97 1.3× 20 0.3× 88 2.0× 19 0.6× 21 0.7× 38 290
Yuki Sekido Japan 10 108 1.5× 63 1.0× 47 1.0× 63 1.9× 27 0.9× 46 269
Stephen DeWall United States 7 52 0.7× 93 1.5× 124 2.8× 38 1.1× 10 0.3× 12 227
Mikiya Ishihara Japan 8 146 2.0× 100 1.6× 65 1.4× 29 0.9× 14 0.5× 35 234
Matthew W. Anderson United States 7 36 0.5× 168 2.7× 72 1.6× 19 0.6× 19 0.6× 12 281
Felix Weihsengruber Austria 8 122 1.7× 41 0.7× 39 0.9× 28 0.8× 98 3.3× 15 253
Diego Bertoli Italy 9 52 0.7× 126 2.0× 48 1.1× 37 1.1× 52 1.7× 24 254
Zhi‐Bo Zhang China 8 48 0.7× 13 0.2× 90 2.0× 23 0.7× 19 0.6× 33 250
Jack Bibby United States 6 44 0.6× 139 2.2× 101 2.2× 23 0.7× 9 0.3× 13 259

Countries citing papers authored by Valery Volk

Since Specialization
Citations

This map shows the geographic impact of Valery Volk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valery Volk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valery Volk more than expected).

Fields of papers citing papers by Valery Volk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valery Volk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valery Volk. The network helps show where Valery Volk may publish in the future.

Co-authorship network of co-authors of Valery Volk

This figure shows the co-authorship network connecting the top 25 collaborators of Valery Volk. A scholar is included among the top collaborators of Valery Volk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valery Volk. Valery Volk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Schulte-Schrepping, Jonas, Florian Tran, Jan Taubenheim, et al.. (2025). P0092 Advancing precision medicine in IBD: Systematic evaluation of single-cell transcriptomics protocols for intestinal biopsies. Journal of Crohn s and Colitis. 19(Supplement_1). i460–i461. 1 indexed citations
2.
Wegwitz, Florian, Tiago De Oliveira, Lena‐Christin Conradi, et al.. (2025). Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition. Cell Death and Differentiation. 32(9). 1734–1749. 5 indexed citations
3.
Mundt, Bettina, Norman Woller, Valery Volk, et al.. (2025). Oncolytic viruses expressing MATEs facilitate target-independent T-cell activation in tumors. EMBO Molecular Medicine. 17(2). 265–300.
4.
Graeser, Monika, Oleg Gluz, Peter Schmid, et al.. (2024). Multiomic factor analysis for pathologic complete response (pCR) after 12 weeks of pembrolizumab + trastuzumab + pertuzumab in HER2-enriched (HER2-E) early breast cancer (eBC) in the Keyriched-1 trial.. Journal of Clinical Oncology. 42(16_suppl). 590–590. 1 indexed citations
5.
Welz, Lina, Abdulkhaliq Alsaadi, Jan Taubenheim, et al.. (2024). P224 JAK-STAT-Driven Tryptophan Degradation Fuels Mucosal Inflammation through QPRT Suppression-Induced Quinolinic Acid Overflow. Journal of Crohn s and Colitis. 18(Supplement_1). i554–i554. 1 indexed citations
6.
Volk, Valery, Bernd Auber, Detlef Trost, et al.. (2023). Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families. Acta Neuropathologica Communications. 11(1). 184–184. 2 indexed citations
7.
Weber, Jonathan, Roberta Carriero, Valery Volk, et al.. (2022). Understanding fibrosis pathogenesis via modeling macrophage-fibroblast interplay in immune-metabolic context. Nature Communications. 13(1). 6499–6499. 32 indexed citations
8.
Verstockt, Bram, Valery Volk, Dahham Alsoud, et al.. (2022). Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics. 56(2). 282–291. 9 indexed citations
9.
Hermsen, Meyke, Valery Volk, Jan Hinrich Bräsen, et al.. (2021). Quantitative assessment of inflammatory infiltrates in kidney transplant biopsies using multiplex tyramide signal amplification and deep learning. Laboratory Investigation. 101(8). 970–982. 30 indexed citations
10.
Danisch, Simon, Reinhard Zeidler, Frank Klawonn, et al.. (2020). CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease. Molecular Therapy — Oncolytics. 18. 504–524. 50 indexed citations
11.
Volk, Valery, Sebastian J. Theobald, Susanne Rittinghausen, et al.. (2017). Human Effector Memory T Helper Cells Engage with Mouse Macrophages and Cause Graft-versus-Host–Like Pathology in Skin of Humanized Mice Used in a Nonclinical Immunization Study. American Journal Of Pathology. 187(6). 1380–1398. 18 indexed citations
12.
Volk, Valery, Philippe A. Robert, Loukia M. Spineli, et al.. (2017). Multidimensional Analysis Integrating Human T-Cell Signatures in Lymphatic Tissues with Sex of Humanized Mice for Prediction of Responses after Dendritic Cell Immunization. Frontiers in Immunology. 8. 1709–1709. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026